404 related articles for article (PubMed ID: 31615089)
1. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
[TBL] [Abstract][Full Text] [Related]
2. Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis.
Jayaraj R; Polpaya K; Kunale M; Kodiveri Muthukaliannan G; Shetty S; Baxi S; Mani RR; Paranjothy C; Purushothaman V; Kayarohanam S; Janakiraman AK; Balaraman AK
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553594
[No Abstract] [Full Text] [Related]
3. Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis.
Jayaraj R; Raymond G; Krishnan S; Tzou KS; Baxi S; Ram MR; Govind SK; Chandramoorthy HC; Abu-Khzam FN; Shaw P
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397507
[No Abstract] [Full Text] [Related]
4. Molecular Investigation of miRNA Biomarkers as Chemoresistance Regulators in Melanoma: A Protocol for Systematic Review and Meta-Analysis.
Shaw P; Raymond G; Tzou KS; Baxi S; Mani RR; Kumar Govind S; Chandramoorthy HC; Sivanandy P; Rajagopal M; Samiappan S; Krishnan S; Jayaraj R
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052456
[TBL] [Abstract][Full Text] [Related]
5. Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies.
Madurantakam Royam M; Kumarasamy C; Baxi S; Gupta A; Ramesh N; Kodiveri Muthukaliannan G; Jayaraj R
Mol Diagn Ther; 2019 Feb; 23(1):65-82. PubMed ID: 30726546
[TBL] [Abstract][Full Text] [Related]
6. Clinical Theragnostic Relationship between Chemotherapeutic Resistance, and Sensitivity and miRNA Expressions in Head and Neck Cancers: A Systematic Review and Meta-Analysis Protocol.
Shaw P; Raymond G; Senthilnathan R; Kumarasamy C; Baxi S; Suresh D; Shetty S; Ram M R; Chandramoorthy HC; Sivanandy P; Samiappan S; Rajagopal M; Krishnan S; Jayaraj R
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946979
[No Abstract] [Full Text] [Related]
7. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
8. Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta‑analysis.
Zhu Z; Jiang H; Xie J; Jin X; Li B; Liu J
Sci Rep; 2022 Dec; 12(1):22016. PubMed ID: 36539545
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of microRNAs in head and neck cancers: a systematic review and meta-analysis protocol.
Kumarasamy C; Devi A; Jayaraj R
Syst Rev; 2018 Oct; 7(1):150. PubMed ID: 30285880
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma.
Sabarimurugan S; Kumarasamy C; Baxi S; Devi A; Jayaraj R
PLoS One; 2019; 14(2):e0209760. PubMed ID: 30735523
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract][Full Text] [Related]
12. A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.
Shaw P; Senthilnathan R; Krishnan S; Suresh D; Shetty S; Muthukaliannan GK; Mani RR; Sivanandy P; Chandramoorthy HCK; Gupta MM; Baxi S; Jayaraj R
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503179
[No Abstract] [Full Text] [Related]
13. miRNA as promising theragnostic biomarkers for predicting radioresistance in cancer: A systematic review and meta-analysis.
Mohammadi C; Gholamzadeh Khoei S; Fayazi N; Mohammadi Y; Najafi R
Crit Rev Oncol Hematol; 2021 Jan; 157():103183. PubMed ID: 33310279
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
15. The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues.
Chen X; Lu P; Wang DD; Yang SJ; Wu Y; Shen HY; Zhong SL; Zhao JH; Tang JH
Gene; 2016 Dec; 595(2):221-226. PubMed ID: 27746365
[TBL] [Abstract][Full Text] [Related]
16. miRNA Predictors of Pancreatic Cancer Chemotherapeutic Response: A Systematic Review and Meta-Analysis.
Madurantakam Royam M; Ramesh R; Shanker R; Sabarimurugan S; Kumarasamy C; Ramesh N; Gothandam KM; Baxi S; Gupta A; Krishnan S; Jayaraj R
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31252688
[TBL] [Abstract][Full Text] [Related]
17. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
18. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
19. Candidate miRNAs in human breast cancer biomarkers: a systematic review.
Adhami M; Haghdoost AA; Sadeghi B; Malekpour Afshar R
Breast Cancer; 2018 Mar; 25(2):198-205. PubMed ID: 29101635
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.
Sabarimurugan S; Madurantakam Royam M; Das A; Das S; K M G; Jayaraj R
Mol Diagn Ther; 2018 Dec; 22(6):653-669. PubMed ID: 30259393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
